Spital Thurgau, Sana Kliniken, Oxford University Hospitals NHS Foundation Trust, and Novo Nordisk are honourable partners at AUTOMA+ 2023. Together with healthcare innovators and experts, companies met at the Congress to share insights about innovative health. They discuss technologies for the whole value chain of the healthcare industry.
Healthcare Automation and Digitalization Congress 2023 discussed game-changing industry trends and technologies. This event took place in Zurich, Switzerland, on September 25–26. Professionals from the whole value chain of the healthcare industry, including Sanofi, Pfizer, Takeda, Merck, Roche, Hirslanden Klinik, Humanitas Research Hospital, and Kantonsspital Aarau AG, exchanged experiences and discussed the directions for an innovative future.
The first day of the Congress started with the executive opening panel, where speakers from EUSPA (EU Agency for the Space Programme), Spital Thurgau, United Medical Group CY/European Medical Center, Mayo Clinic Laboratories, and Kanton Spital Winterthur discussed aspects of the sustainable digital healthcare ecosystem. The executive opening panel started with the welcoming speech of the Project Director of AUTOMA+ 2023, Yuliya Glazyrina:
The two-day business programme of AUTOMA+ 2023 comprised different formats of the sessions including leaders talks, roundtables, and panel discussions. Speakers shared their thoughts and insights on the up-to-date topics such as hospitals of the future, healthcare 5.0, AI and robotics, digital privacy and many others. The business programme also included a new format of workshops, and closed-door sessions, where speakers directly interacted with the audience. At the workshops, honourable partners, Oxford University Hospitals NHS Foundation Trust and Sana Klinikum Offenbach GmbH/Sana Kliniken AG presented VR technologies for training the health professionals of tomorrow and discussed digital health technology adoption.
With the aim to expand the professional network for mutual growth and deepen the knowledge of industry digital transformation, the next editions of AUTOMA+ will change its focus to automation and digitalisation in the pharmaceutical industry. This way, the name for next edition of AUTOMA+ is the Pharmaceutical Automation and Digitalisation Congress 2024. BGS Group would like to thank the participants for their valuable support and invite leaders and pioneers of the pharmaceutical sector at AUTOMA+ 2024 in Geneva, Switzerland, on November 18-19, 2024.
Visit the official website of AUTOMA+ 2024 for more information: https://sh.bgs.group/zo